Skip to content

Effect of oral nutritional supplements on the nutritional status and immune function of peritoneal dialysis patients

Effect of oral nutritional supplements on the nutritional status and immune function of peritoneal dialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083657
Enrollment
Unknown
Registered
2024-04-29
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage renal disease

Interventions

MFGM-enriched oral nutritional supplements group:Oral nutritional supplement enriched with milk fat globular membrane protein was given once daily between meals and dietary guidance was given.
Standard oral nutritional supplement group:Oral nutritional supplements with the same macronutrient ratio and energy as MFGM group were given once a day between meals, and dietary guidance was given.
Control group:Dietary guidance is given by a professional dietitian according to the guidelines.

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 80 years old, BMI<25 kg/m2. 2. Maintenance peritoneal dialysis, stable dialysis for more than three months; 3. Serum albumin < 38 g/L 4. Capable of taking in oral food; 5. The study object understood and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, liver, and lung diseases, autoimmune diseases, active malignant tumors, severe gastrointestinal diseases, and a history of gastrointestinal surgery; 2. Serious infections such as peritonitis, endocarditis, soft tissue infections, pneumonia, etc. occurred within the past 1 months; 3. Patients who use oral energy supplements, antibiotics, micro-ecological modulators, gastrointestinal motility drugs and other agents affecting the intestinal flora within the past 1 months; 4. Type 1 diabetes mellitus or type 2 diabetes mellitus with HbA1c > 9%; 5. Use of amino acid dialysate; 6. The efficiency of peritoneal dialysis is poor, Kt/v < 1.4; 7. Patients who have participated in other research projects in the past 3 months. 8. Pregnant or lactating women; 9. Allergies to any component of oral nutritional supplements; 10. Subject is considered unsuitable for the study based on the study physician's assessment.

Design outcomes

Primary

MeasureTime frame
Albumin;Intestinal flora;

Secondary

MeasureTime frame
MIS;Prealbumin;TP;Serum transferrin;hs-CRP;Inflammatory cytokines;Expression level of T lymphocyte subsets in peripheral blood;Serum immunoglobulin levels;KDQOL-36;Body composition analysis;Adequacy of dialysis;

Countries

China

Contacts

Public ContactLi Juan

Shanghai Changzheng Hospital

yyk3020@163.com+86 139 1795 7979

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026